FIG. 4A is a graph showing the decreased thioredoxin mRNA levels in the human liver cancer cell line HepG2 following treatment with 6 antisense oligonucleotides complementary to the thioredoxin mRNA as a percentage of the mRNA levels in the untreated cell line.